Literature DB >> 29435656

[Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Robert Larbig1, Markus Bettin2, Lukas J Motloch3, Alicia Fischer2, Niklas Bode2, Gerrit Frommeyer2, Florian Reinke2, Andreas Loeher4, Lars Eckardt2, Julia Köbe2.   

Abstract

Inappropriate shocks are a feared complication after implantable cardioverter-defibrillator (ICD) implantation and have a tremendous impact on quality of life. Inappropriate shocks in patients with subcutaneous ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) have various underlying causes. This review summarizes the current literature on this topic and lists possible treatment options.

Entities:  

Keywords:  Inappropriate shocks; Oversensing; Programming; S-ICD®; Sudden cardiac death

Mesh：

Year:  2018        PMID： 29435656     DOI： 10.1007/s00399-018-0555-1

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  29 in total

1.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesús Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark Mcguire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  Europace       Date:  2015-11-19       Impact factor: 5.214

2.  Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.

Authors:  Niccoló Maurizi; Ilaria Tanini; Iacopo Olivotto; Ernesto Amendola; Giuseppe Limongelli; Maria Angela Losi; Giuseppe Allocca; Giovanni Battista Perego; Paolo Pieragnoli; Giuseppe Ricciardi; Paolo De Filippo; Paola Ferrari; Giovanni Quarta; Stefano Viani; Antonio Rapacciuolo; Maria Grazia Bongiorni; Franco Cecchi
Journal:  Int J Cardiol       Date:  2017-01-04       Impact factor: 4.164

3.  Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.

Authors:  Michael R Gold; Raul Weiss; Dominic A M J Theuns; Warren Smith; Angel Leon; Bradley P Knight; Nathan Carter; Michael Husby; Martin C Burke
Journal:  Heart Rhythm       Date:  2014-04-13       Impact factor: 6.343

4.  Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Authors:  Tsukasa Kamakura; Mitsuru Wada; Kohei Ishibashi; Yuko Y Inoue; Koji Miyamoto; Hideo Okamura; Satoshi Nagase; Takashi Noda; Takeshi Aiba; Satoshi Yasuda; Kengo Kusano
Journal:  Heart Vessels       Date:  2017-05-18       Impact factor: 2.037

5.  Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

Authors:  Lucas Boersma; Craig Barr; Reinoud Knops; Dominic Theuns; Lars Eckardt; Petr Neuzil; Marcoen Scholten; Margaret Hood; Juergen Kuschyk; Paul Jones; Elizabeth Duffy; Michael Husby; Kenneth Stein; Pier D Lambiase
Journal:  J Am Coll Cardiol       Date:  2017-08-15       Impact factor: 24.094

6.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Authors:  Louise R A Olde Nordkamp; Lara Dabiri Abkenari; Lucas V A Boersma; Alexander H Maass; Joris R de Groot; Antonie J H H M van Oostrom; Dominic A M J Theuns; Luc J L M Jordaens; Arthur A M Wilde; Reinoud E Knops
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

7.  Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Andreas Löher; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-08-02       Impact factor: 5.460

8.  Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Simon Kochhäuser; Markus Bettin; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  J Interv Card Electrophysiol       Date:  2016-05-23       Impact factor: 1.900

9.  Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing.

Authors:  Ali A Sovari; Ashkan Ehdaie; Qiang Liu; Xunzhang Wang; Charles Swerdlow; Michael Shehata
Journal:  HeartRhythm Case Rep       Date:  2016-12-29

10.  Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block.

Authors:  Maria João Sousa; Tim Betts
Journal:  J Arrhythm       Date:  2016-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.